Tel:+86-21-51950625 51950635
Email us at sales@koutingchina.com
   
Products
Rosuvastatin 
7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid
(CAS 287714-41-4)
Description:

Rosuvastatin is a competitive inhibitor of HMG-CoA reductase with IC50 of 11 nM.

HMG-CoA reductase is the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the “statin” class of cholesterol-lowering drugs.Rosuvastatin is a synthetic statin that inhibits HMG-CoA reductase with an IC50 value of 5 nM.With a maximal effective dose at 40 mg/day, rosuvastatin was shown in the STELLAR clinical study to be more effective than atorvastatin, simvastatin, or pravastatin  in decreasing LDL cholesterol and increasing HDL cholesterol.

 

Product No. KT00774 
Product Name Rosuvastatin 
Synonyms ZD 4522;X-Plended
Formal Name 7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid
CAS Number 287714-41-4
Molecular Formula C22H28FN3O6S
Formula Weight 481.54
Formulation A crystalline solid
Purity 98%min
Stability 2 years
Storage -20°C
Shipping USD45 for Europe and USA. No shipping charge once amount reach USD500
Quality Control HNMR,CNMR,LCMS,HPLC,IR,etc.
Price & Availability In Stock. Price Negotiated.
 
Not found? Pls contact with us for sourcing service.
Our contact email:sales@koutingchina.com
 
 
 
 
Related Products:
HMG-CoA Reductase 
Pravastatin
Pravastatin (sodium salt)
Simvastatin
Atorvastatin
Atorvastatin hemicalcium salt
Fluvastatin
Fluvastatin sodium

Order the product  * is required
Product:*
Your Name:*
Your Company:*
Add:
Tel:
Fax:
Web:
E-Mail:*
Your Demand :*

Products are for research use only. Not for human use. We do not sell to patients.
Copyrigh ©2009,China Kouting Group Limited All Rights Reserved. Supported by hxchem.net


products
Customer Service
Why Choose Us?
How to Order
How to Ship
How to Return
Frequently Asked Questions
Terms and Conditions
Email:sales@koutingchina.com
Skype: Notice